table of content
1 Molecular Diagnostics Systems Market Overview
1.1 Product Overview and Scope of Molecular Diagnostics Systems
1.2 Molecular Diagnostics Systems Segment by Type
1.2.1 Global Molecular Diagnostics Systems Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 PCR
1.2.3 Hybridization
1.2.4 DNA Sequencing
1.3 Molecular Diagnostics Systems Segment by Application
1.3.1 Global Molecular Diagnostics Systems Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Laboratories
1.4 Global Molecular Diagnostics Systems Market Size Estimates and Forecasts
1.4.1 Global Molecular Diagnostics Systems Revenue 2017-2028
1.4.2 Global Molecular Diagnostics Systems Sales 2017-2028
1.4.3 Molecular Diagnostics Systems Market Size by Region: 2017 Versus 2021 Versus 2028
2 Molecular Diagnostics Systems Market Competition by Manufacturers
2.1 Global Molecular Diagnostics Systems Sales Market Share by Manufacturers (2017-2022)
2.2 Global Molecular Diagnostics Systems Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Molecular Diagnostics Systems Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Molecular Diagnostics Systems Manufacturing Sites, Area Served, Product Type
2.5 Molecular Diagnostics Systems Market Competitive Situation and Trends
2.5.1 Molecular Diagnostics Systems Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Molecular Diagnostics Systems Players Market Share by Revenue
2.5.3 Global Molecular Diagnostics Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Molecular Diagnostics Systems Retrospective Market Scenario by Region
3.1 Global Molecular Diagnostics Systems Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Molecular Diagnostics Systems Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Molecular Diagnostics Systems Market Facts & Figures by Country
3.3.1 North America Molecular Diagnostics Systems Sales by Country
3.3.2 North America Molecular Diagnostics Systems Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Molecular Diagnostics Systems Market Facts & Figures by Country
3.4.1 Europe Molecular Diagnostics Systems Sales by Country
3.4.2 Europe Molecular Diagnostics Systems Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Molecular Diagnostics Systems Market Facts & Figures by Region
3.5.1 Asia Pacific Molecular Diagnostics Systems Sales by Region
3.5.2 Asia Pacific Molecular Diagnostics Systems Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Molecular Diagnostics Systems Market Facts & Figures by Country
3.6.1 Latin America Molecular Diagnostics Systems Sales by Country
3.6.2 Latin America Molecular Diagnostics Systems Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Molecular Diagnostics Systems Market Facts & Figures by Country
3.7.1 Middle East and Africa Molecular Diagnostics Systems Sales by Country
3.7.2 Middle East and Africa Molecular Diagnostics Systems Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Molecular Diagnostics Systems Historic Market Analysis by Type
4.1 Global Molecular Diagnostics Systems Sales Market Share by Type (2017-2022)
4.2 Global Molecular Diagnostics Systems Revenue Market Share by Type (2017-2022)
4.3 Global Molecular Diagnostics Systems Price by Type (2017-2022)
5 Global Molecular Diagnostics Systems Historic Market Analysis by Application
5.1 Global Molecular Diagnostics Systems Sales Market Share by Application (2017-2022)
5.2 Global Molecular Diagnostics Systems Revenue Market Share by Application (2017-2022)
5.3 Global Molecular Diagnostics Systems Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Abbott Laboratories Molecular Diagnostics Systems Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Qiagen N.V.
6.2.1 Qiagen N.V. Corporation Information
6.2.2 Qiagen N.V. Description and Business Overview
6.2.3 Qiagen N.V. Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Qiagen N.V. Molecular Diagnostics Systems Product Portfolio
6.2.5 Qiagen N.V. Recent Developments/Updates
6.3 Roche Diagnostics
6.3.1 Roche Diagnostics Corporation Information
6.3.2 Roche Diagnostics Description and Business Overview
6.3.3 Roche Diagnostics Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Roche Diagnostics Molecular Diagnostics Systems Product Portfolio
6.3.5 Roche Diagnostics Recent Developments/Updates
6.4 Hologic, Inc.
6.4.1 Hologic, Inc. Corporation Information
6.4.2 Hologic, Inc. Description and Business Overview
6.4.3 Hologic, Inc. Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Hologic, Inc. Molecular Diagnostics Systems Product Portfolio
6.4.5 Hologic, Inc. Recent Developments/Updates
6.5 Grifols
6.5.1 Grifols Corporation Information
6.5.2 Grifols Description and Business Overview
6.5.3 Grifols Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Grifols Molecular Diagnostics Systems Product Portfolio
6.5.5 Grifols Recent Developments/Updates
6.6 Siemens Healthcare
6.6.1 Siemens Healthcare Corporation Information
6.6.2 Siemens Healthcare Description and Business Overview
6.6.3 Siemens Healthcare Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Siemens Healthcare Molecular Diagnostics Systems Product Portfolio
6.6.5 Siemens Healthcare Recent Developments/Updates
6.7 Becton, Dickinson and Company
6.6.1 Becton, Dickinson and Company Corporation Information
6.6.2 Becton, Dickinson and Company Description and Business Overview
6.6.3 Becton, Dickinson and Company Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Becton, Dickinson and Company Molecular Diagnostics Systems Product Portfolio
6.7.5 Becton, Dickinson and Company Recent Developments/Updates
6.8 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
6.8.1 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Corporation Information
6.8.2 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Description and Business Overview
6.8.3 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Product Portfolio
6.8.5 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Recent Developments/Updates
6.9 Biom?rieux Sa
6.9.1 Biom?rieux Sa Corporation Information
6.9.2 Biom?rieux Sa Description and Business Overview
6.9.3 Biom?rieux Sa Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Biom?rieux Sa Molecular Diagnostics Systems Product Portfolio
6.9.5 Biom?rieux Sa Recent Developments/Updates
6.10 Cepheid Inc
6.10.1 Cepheid Inc Corporation Information
6.10.2 Cepheid Inc Description and Business Overview
6.10.3 Cepheid Inc Molecular Diagnostics Systems Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Cepheid Inc Molecular Diagnostics Systems Product Portfolio
6.10.5 Cepheid Inc Recent Developments/Updates
7 Molecular Diagnostics Systems Manufacturing Cost Analysis
7.1 Molecular Diagnostics Systems Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Molecular Diagnostics Systems
7.4 Molecular Diagnostics Systems Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Molecular Diagnostics Systems Distributors List
8.3 Molecular Diagnostics Systems Customers
9 Molecular Diagnostics Systems Market Dynamics
9.1 Molecular Diagnostics Systems Industry Trends
9.2 Molecular Diagnostics Systems Market Drivers
9.3 Molecular Diagnostics Systems Market Challenges
9.4 Molecular Diagnostics Systems Market Restraints
10 Global Market Forecast
10.1 Molecular Diagnostics Systems Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Molecular Diagnostics Systems by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Molecular Diagnostics Systems by Type (2023-2028)
10.2 Molecular Diagnostics Systems Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Molecular Diagnostics Systems by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Molecular Diagnostics Systems by Application (2023-2028)
10.3 Molecular Diagnostics Systems Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Molecular Diagnostics Systems by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Molecular Diagnostics Systems by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
